» Articles » PMID: 30206370

Carbonic Anhydrase IX is a PH-stat That Sets an Acidic Tumour Extracellular PH in Vivo

Overview
Journal Br J Cancer
Specialty Oncology
Date 2018 Sep 13
PMID 30206370
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Tumour carbonic anhydrase IX (CAIX), a hypoxia-inducible tumour-associated cell surface enzyme, is thought to acidify the tumour microenvironment by hydrating CO to form protons and bicarbonate, but there is no definitive evidence for this in solid tumours in vivo.

Methods: We used H magnetic resonance spectroscopic imaging (MRSI) of the extracellular pH probe imidazolyl succinic acid (ISUCA) to measure and spatially map extracellular pH in HCT116 tumours transfected to express CAIX and empty vector controls in SCID mice. We also measured intracellular pH in situ with P MRS and measured lactate in freeze-clamped tumours.

Results: CAIX-expressing tumours had 0.15 pH-unit lower median extracellular pH than control tumours (pH 6.71 tumour vs pH 6.86 control, P = 0.01). Importantly, CAIX expression imposed an upper limit for tumour extracellular pH at 6.93. Despite the increased lactate concentration in CAIX-expressing tumours, P MRS showed no difference in intracellular pH, suggesting that CAIX acidifies only the tumour extracellular space.

Conclusions: CAIX acidifies the tumour microenvironment, and also provides an extracellular pH control mechanism. We propose that CAIX thus acts as an extracellular pH-stat, maintaining an acidic tumour extracellular pH that is tolerated by cancer cells and favours invasion and metastasis.

Citing Articles

Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma.

Zheng Y, Wang J, Zhao G, Zhang Z, Shao Y, Lu B J Immunother Cancer. 2025; 13(1.

PMID: 39755580 PMC: 11749828. DOI: 10.1136/jitc-2024-010521.


Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production.

Yang J, Tong X, Wang W, Yu X, Xu J, Shi S Cell Oncol (Dordr). 2024; 47(6):2367-2382.

PMID: 39656421 DOI: 10.1007/s13402-024-01022-9.


Hypoxia-related carbonic anhydrase 9 induces serpinB9 expression in cancer cells and apoptosis in T cells via acidosis.

Harada M, Kotani H, Iida Y, Tanino R, Minami T, Komohara Y Cancer Sci. 2024; 115(5):1405-1416.

PMID: 38413363 PMC: 11093193. DOI: 10.1111/cas.16133.


Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold.

Romagnoli R, De Ventura T, Manfredini S, Baldini E, Supuran C, Nocentini A J Enzyme Inhib Med Chem. 2023; 38(1):2270180.

PMID: 37850364 PMC: 10586084. DOI: 10.1080/14756366.2023.2270180.


Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA).

Ali J, Walter M Cancer Cell Int. 2023; 23(1):197.

PMID: 37679807 PMC: 10483736. DOI: 10.1186/s12935-023-03041-2.


References
1.
Tkac I, Starcuk Z, Choi I, Gruetter R . In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med. 1999; 41(4):649-56. DOI: 10.1002/(sici)1522-2594(199904)41:4<649::aid-mrm2>3.0.co;2-g. View

2.
Stubbs M, McSheehy P, Griffiths J . Causes and consequences of acidic pH in tumors: a magnetic resonance study. Adv Enzyme Regul. 1999; 39:13-30. DOI: 10.1016/s0065-2571(98)00018-1. View

3.
Stubbs M, Bhujwalla Z, Tozer G, Rodrigues L, Maxwell R, Morgan R . An assessment of 31P MRS as a method of measuring pH in rat tumours. NMR Biomed. 1992; 5(6):351-9. DOI: 10.1002/nbm.1940050606. View

4.
Troost E, Bussink J, Kaanders J, van Eerd J, Peters J, Rijken P . Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines. Radiother Oncol. 2005; 76(2):194-9. DOI: 10.1016/j.radonc.2005.06.031. View

5.
Mayer A, Hockel M, Vaupel P . Carbonic anhydrase IX expression and tumor oxygenation status do not correlate at the microregional level in locally advanced cancers of the uterine cervix. Clin Cancer Res. 2005; 11(20):7220-5. DOI: 10.1158/1078-0432.CCR-05-0869. View